Tretinoin Safety for Young Adults (Ages 18 to 29): What You Need to Know
A guide to tretinoin topical safety for young adults aged 18 to 29, covering dosing, side effects, pregnancy risks, fertility considerations, and long-term use evidence.
Tretinoin and Autoimmune Disease: What Clinicians and Patients Need to Know
A clinical guide to using topical tretinoin in patients with autoimmune conditions, covering photosensitivity, disease-specific caution points, comedication interactions, and a decision framework for prescribing.
How to Get Vaginal Estradiol in Washington State
A complete guide to obtaining a vaginal estradiol prescription in Washington, covering telehealth visits, labs, pharmacies, Medicaid prior authorization, and compounding options.
Vaginal Estradiol and Autoimmune Disease: What Clinicians and Patients Need to Know
A guide to vaginal estradiol use in autoimmune disease, covering systemic absorption, disease-specific safety data, drug interactions, and monitoring recommendations for lupus, Sjögren syndrome, RA, and MS.
Vaginal Estradiol Cardiovascular Impact: Long-Term Safety Evidence
A clinician-level review of vaginal estradiol's long-term cardiovascular safety, including systemic absorption data, WHI subgroup analyses, and current NAMS/ACOG prescribing guidance for women with genitourinary syndrome of menopause.
Vaginal Estradiol Dosing in Hepatic Impairment
A clinician-level guide to vaginal estradiol dosing, mechanism, and safety adjustments in patients with hepatic impairment, with PubMed- and FDA-cited evidence.
Does State Medicaid Cover Vaginal Estradiol? A State-by-State Coverage Guide
Learn whether your state Medicaid plan covers vaginal estradiol for genitourinary syndrome of menopause, what prior authorization criteria apply, how step therapy works, and how to appeal a denial.
Vaginal Estradiol: Metabolism and Energy Expenditure
A deep dive into how vaginal estradiol is absorbed, metabolized, and whether low-dose local therapy meaningfully affects resting energy expenditure, thermogenesis, or body composition in menopausal women.
Vaginal Estradiol Seasonal Use Considerations
A clinician-level guide to adjusting vaginal estradiol (Vagifem, Yuvafem, Imvexxy) dosing, formulation, and monitoring across seasons, with primary-literature citations and practical prescribing guidance.
Does State Medicaid Cover Vardenafil (Levitra/Staxyn)?
A state-by-state breakdown of Medicaid coverage for vardenafil (Levitra/Staxyn), including prior authorization criteria, formulary tiers, step therapy requirements, appeal rights, and cost alternatives.
Viagra and Autoimmune Disease: What Patients and Clinicians Need to Know
A clinician-level review of sildenafil (Viagra) use in autoimmune and inflammatory conditions, covering pharmacology, drug interactions, disease-specific guidance, and safety data from primary literature.
Viagra (Sildenafil) Geriatric Monitoring: What Clinicians and Patients Over 65 Need to Know
A complete clinical guide to monitoring sildenafil (Viagra) in patients aged 65 and older, covering dose adjustments, drug interactions, cardiovascular checks, fall risk, and when to deprescribe.
Viagra Pharmacogenomics & Genetic Variability: How Your DNA Shapes Sildenafil Response
Explore sildenafil genetics, CYP3A4 metabolism and erectile-function studies, plus the dosing factors and medication checks that guide Viagra treatment.
Viagra Pharmacokinetics (ADME): How Sildenafil Is Absorbed, Distributed, Metabolized, and Excreted
An MD-level breakdown of sildenafil (Viagra) pharmacokinetics covering absorption, distribution, metabolism, and excretion, with primary PubMed and FDA citations throughout.
Does TRICARE Cover Viagra (Sildenafil)? Coverage, Prior Auth, and Appeals Explained
A complete guide to TRICARE coverage for Viagra (sildenafil): formulary status, prior authorization criteria, step therapy requirements, denial appeals, and cost-saving alternatives for military beneficiaries.
Viagra (Sildenafil) Dosing for Young Adults Ages 18 to 29
A guide to sildenafil dosing for men aged 18 to 29, covering starting doses, titration, timing, drug interactions, and when ED in young men warrants further workup.
Vyvanse Appetite & Cravings Changes: What the Clinical Evidence Shows
Vyvanse (lisdexamfetamine) is FDA-approved for moderate-to-severe binge eating disorder in adults at 50-70 mg, with roughly 1.6 fewer binge days a week.
Vyvanse Cognitive Function Impact: What the Clinical Evidence Actually Shows
A deep dive into how lisdexamfetamine (Vyvanse) affects cognitive function in ADHD and binge eating disorder, covering mechanisms, clinical trial data, dosing, and safety.
Vyvanse Week by Week: What to Expect in Your First Month on Lisdexamfetamine
A week-by-week guide to the first 30 days on Vyvanse (lisdexamfetamine) for ADHD and binge eating disorder, including dose titration, side-effect timelines, and what the clinical evidence actually shows.
Vyvanse Food and Supplements: Match the Ingredient to the Evidence
Separate capsule mixing, urinary-pH interactions, omeprazole and caffeine study outcomes before interpreting a Vyvanse food or supplement effect.
Vyvanse Monitoring Schedule: Labs & Exams Your Prescriber Should Order
A clinician-level guide to the complete Vyvanse (lisdexamfetamine) monitoring schedule, covering baseline labs, follow-up cardiovascular exams, growth tracking, abuse-potential assessments, and when to escalate care.
Vyvanse (Lisdexamfetamine) After Bariatric Surgery: What Clinicians and Patients Need to Know
A clinical deep-dive into lisdexamfetamine (Vyvanse) pharmacokinetics, dosing, absorption changes, and safety considerations following Roux-en-Y gastric bypass, sleeve gastrectomy, and other bariatric procedures.
Vyvanse (Lisdexamfetamine) Pregnancy & Lactation Safety
An evidence-based guide to lisdexamfetamine (Vyvanse) use during pregnancy and breastfeeding, covering pharmacokinetics, fetal risk data, neonatal outcomes, and clinical decision frameworks.
Vyvanse Regulatory Status: US, EU, Canada, and UK Explained
Is Vyvanse a controlled substance? Yes: it is DEA Schedule II in the US, CDSA Schedule I in Canada, and a Class B Schedule 2 controlled drug in the UK.
Vyvanse (Lisdexamfetamine) and the Kidneys: Renal Protection or Renal Risk?
A clinician-level review of how Vyvanse (lisdexamfetamine) affects kidney function, covering renal excretion pharmacokinetics, blood-pressure-driven risk, dose adjustment in CKD, and what current evidence says about long-term renal safety.
Vyvanse Seasonal Use Considerations: A Clinical Guide to Lisdexamfetamine Year-Round
How temperature, light cycles, schedule changes, and seasonal mood shifts affect Vyvanse (lisdexamfetamine) dosing, storage, and clinical management. Board-reviewed guidance with primary-literature citations.
Does Blue Cross Blue Shield (Federated) Cover Wegovy?
A guide to Blue Cross Blue Shield (Federated) Wegovy coverage, prior authorization criteria, step therapy requirements, formulary placement, and how to appeal a denial.
Wegovy: How to Safely Stop Semaglutide 2.4 mg
A guide to stopping Wegovy (semaglutide 2.4 mg) safely, covering tapering approaches, rebound weight risk, managing withdrawal symptoms, and when to restart or switch medications.
Wegovy Manufacturing, Supply & Shortage History
A complete clinical and operational history of Wegovy (semaglutide 2.4 mg) manufacturing, global supply constraints, FDA shortage listings, and what the pipeline looks like for 2025 and beyond.
Does Medicare Advantage Cover Wegovy?
A complete clinical and coverage guide to Medicare Advantage coverage for Wegovy (semaglutide 2.4 mg), including prior authorization criteria, formulary status, step therapy requirements, appeal pathways, and the post-2024 cardiovascular indication that may change your denial.
Wegovy Dosing for Adults Ages 50 to 64: What Older Adults Need to Know
A guide to Wegovy (semaglutide 2.4 mg) dosing for adults aged 50 to 64, covering the standard titration schedule, age-specific considerations like perimenopause and polypharmacy, cardiovascular benefits, and how to adjust for tolerability.
Wegovy Pharmacokinetics (ADME): How Semaglutide 2.4 mg Is Absorbed, Distributed, Metabolized, and Excreted
An evidence-based breakdown of Wegovy (semaglutide 2.4 mg) pharmacokinetics covering absorption, distribution, metabolism, excretion, drug interactions, and what the data does and does not tell a prescriber or patient.
Wegovy Travel & Timezone-Shift Protocols: Complete Clinical Guide
MD/PharmD-level guide to managing Wegovy (semaglutide 2.4 mg) injection timing, cold-chain storage, and dose adjustments across time zones. Includes specific day-range rules, airport security tips, and nausea management while traveling.
Does UnitedHealthcare Cover Wegovy? Coverage, Prior Auth, and Appeals Explained
A complete guide to UnitedHealthcare Wegovy coverage, prior authorization criteria, formulary tier placement, step therapy requirements, and how to appeal a denial. Reviewed by HealthRX.com physicians.
Wegovy Dosing for Young Adults Ages 18 to 29
A complete clinical guide to Wegovy (semaglutide 2.4 mg) dosing for young adults ages 18-29, including the escalation schedule, fertility considerations, weight-loss evidence, and how to integrate once-weekly injections into an active lifestyle.
Wegovy Safety in Young Adults Ages 18 to 29: What the Evidence Actually Shows
A guide to Wegovy (semaglutide 2.4 mg) safety for adults aged 18 to 29, covering side effects, contraindications, fertility, mental health, and long-term data from STEP trials and FDA labeling.
Bazedoxifene + Conjugated Estrogens (Duavee): The Complete Clinical Guide
A guide to bazedoxifene/conjugated estrogens (Duavee), covering how it works, who qualifies, clinical trial evidence, and how it compares to estradiol patches, gels, sprays, and oral forms.
Estradiol Pellet: How It Compares to Patch, Pill, Gel, and Spray
A comparison of estradiol pellet therapy versus oral, patch, gel (Divigel), and spray delivery. Covers dosing, pharmacokinetics, safety data, and how to choose the right form for your menopause symptoms.
How Long Can You Stay on HRT? Duration, Safety, and When to Stop
Evidence-based guide to HRT duration for women: how long hormone therapy is safe, what guidelines say, when to stop, and how it interacts with contraception and fertility.
HRT After Hysterectomy: Which Surgery Details Change the Plan
Learn which hysterectomy details affect HRT, why ovary removal matters, and what to check in your operation report before discussing your treatment plan.
HRT and Alcohol: What Every Woman on Hormone Therapy Needs to Know
Alcohol is not named as an interaction on the oral Premarin or Duavee labels, but it is linked to higher breast-cancer risk and may worsen hot flashes.
HRT and Fertility: What Women Need to Know Before, During, and After Treatment
Does HRT affect fertility? Learn how estrogen and progesterone therapy interacts with ovulation, pregnancy risk, and reproductive planning at every stage of life.
HRT and Fibroids: What You Need to Know Before Starting Hormone Therapy
Can you take HRT if you have fibroids? Learn how estrogen and progesterone affect fibroid growth, which formulations are safest, and when HRT is appropriate for perimenopausal and postmenopausal women with fibroids.
HRT for Perimenopause: Doses, Timing, and Who Qualifies
A guide to hormone replacement therapy during perimenopause. Covers estrogen and progesterone options, safety data, timing, post-hysterectomy protocols, PCOS considerations, and late postmenopausal use.
HRT vs Veozah (Fezolinetant): Which Menopause Treatment Is Right for You?
A clinical comparison of hormone replacement therapy (HRT) and fezolinetant (Veozah) for menopause symptoms, covering efficacy, safety, delivery methods, and who should choose each option.
HRT With Uterus Intact: What Every Woman Needs to Know
If you have a uterus and are considering HRT, you must take progestogen alongside estrogen to protect the uterine lining. This guide covers regimen types, doses, risks, and how to tailor therapy for perimenopause, late postmenopause, PCOS, and more.
Menopause After Breast Cancer: Symptoms, Diagnosis, and Treatment Options
A comprehensive clinical guide to managing menopause symptoms after breast cancer, including hot flashes, vaginal dryness, and GSM, with evidence-based hormonal and non-hormonal treatment options for survivors.
Menopause Diagnosis: How Doctors Confirm It and What to Do Next
A guide to diagnosing menopause and perimenopause, covering FSH and estradiol testing, symptom criteria, differential diagnosis from thyroid disease, and evidence-based treatment options including HRT, GSM care, and sleep strategies.
Menopause Weight Gain: Causes, Hormones, and What Actually Works
Why women gain weight during menopause and perimenopause, what hormones are responsible, and which treatments including HRT, GLP-1s, and lifestyle changes have the strongest clinical evidence.
Oral Micronized Progesterone: Dosing, Benefits, and How It Compares to Other Estradiol Delivery Forms
A guide to oral micronized progesterone (Prometrium), its role alongside estradiol therapy, dosing schedules, sleep and cardiovascular benefits, and how patches, gels, sprays, and pills differ for menopausal women.
Oral vs Transdermal Estradiol: Which Form Is Right for You?
A comparison of oral and transdermal estradiol for menopausal HRT, covering VTE risk, liver metabolism, dosing, bioidentical options, patches vs gels, and how to choose based on your health profile.
Ospemifene (Osphena): The Non-Estrogen Pill for Vaginal Dryness and Painful Sex
A complete clinical guide to ospemifene (Osphena), the FDA-approved SERM for dyspareunia and vulvovaginal atrophy, with comparisons to estradiol patch, pill, gel, and spray options for menopausal women.
Progesterone vs Progestin: What Every Woman on HRT Needs to Know
Progesterone and progestins protect the uterine lining during HRT, but they differ in molecular structure, side-effect profiles, cardiovascular risk, and breast-cancer signal. This guide covers the clinical evidence so you can have an informed conversation with your prescriber.
Vaginal Dryness and GSM: Causes, Symptoms, and Treatment Options
Genitourinary syndrome of menopause (GSM) affects over 50% of postmenopausal women, causing vaginal dryness, painful sex, and urinary symptoms. Learn what causes GSM, how it's diagnosed, and which treatments, from local estradiol to ospemifene, have the strongest clinical evidence.
Can Menopause Make You Feel 'Crazy'? Mood Swings Causes & Solutions
Menopause-related mood swings, anxiety, and emotional upheaval are real, measurable, and treatable. Learn the neuroscience behind hormonal mood changes and the evidence-based solutions that work.
Does Menopause Cause Fatigue?
Yes, menopause causes fatigue through hormonal shifts, sleep disruption, mood changes, and thyroid interactions. Learn the mechanisms, timeframes, and evidence-based treatments that actually work.
How to Treat Menopause Body Odor: Causes & Solutions
Menopause can change body odor via lower estrogen, sweating, and pH shifts. Learn what helps: HRT, vaginal estrogen, antiperspirants, and lifestyle steps.
How Are Collagen & Estrogen Connected? Changes During Perimenopause Explained
Estrogen directly regulates collagen synthesis, degradation, and skin thickness. Learn exactly how perimenopause-driven estrogen decline accelerates collagen loss, what the research shows, and what clinical options exist.
How to Deal With Menopause Hot Flashes
A guide to evidence-based options for menopause hot flashes, distinguishing FDA-approved treatments, off-label prescriptions, and lifestyle approaches, with a framework for matching severity to next steps.
What Is Facial Bone Resorption or Menopause Face?
Menopause face and facial bone resorption are informal terms, not diagnoses. See what is known about estrogen loss and bone density after menopause.